Effect of Implementing an Educational Module About Inhaler Use on Severity of Dyspnea and Adherence to Inhalation Therapy Among Patients with Chronic Obstructive Pulmonary Disease
American Journal of Nursing Science
Volume 6, Issue 1, February 2017, Pages: 40-52
Received: Dec. 1, 2016; Accepted: Dec. 15, 2016; Published: Jan. 28, 2017
Views 3322      Downloads 126
Authors
Soheir M. Weheida, Department of Medical Surgical Nursing, Faculty of Nursing, Alexandria University, Alexandria, Egypt
Manal E. Fareed, Department of Medical Surgical Nursing, Faculty of Nursing, Menoufia University, Shebin El-Kom, Egypt
Samah E. Masry, Department of Medical Surgical Nursing, Faculty of Nursing, Menoufia University, Shebin El-Kom, Egypt
Article Tools
Follow on us
Abstract
One of the most important routes for medication administration to treat chronic obstructive pulmonary disease patients is the inhaled one. If this method is not proper, medications will not be effective. The aim of this study was to determine the effect of implementing an educational module about inhaler use on severity of dyspnea and adherence to inhalation therapy among patients with chronic obstructive pulmonary disease. A purposive sample of 140 patients with COPD was selected and divided randomly and alternatively into two equal groups, 70 in each. The study was conducted at Chest department and Medical outpatient clinics of Menoufia University and Shebin El-Kom Teaching Hospitals. Five tools were utilized for data collection: Structural interview questionnaire, Bristol COPD knowledge questionnaire, Pressurized metered dose inhaler performance observational checklist, Shortness of breath questionnaire and Morisky Medication adherence scale. Results: 62.9% of study group and 54.3% of control group complained of severe dyspnea pre education, while 44.3% of study group and 54.3% of control group still complained of severe dyspnea one month post education. The improvement of dyspnea among study group than control group was not significant. However medication adherence was significantly improved among study group compared to control group post education. Conclusion: educational module about inhaler use significantly led to improve medication adherence and decrease dyspnea severity however the difference in dyspnea severity among both groups is not significant. Recommendations: Patient's education about correct inhaler use should be ongoing process for all COPD patients and the correct use of inhaler should be observed throughout patient's life.
Keywords
Effect, Educational Modules, Inhaler Use, Dyspnea, Inhalation Therapy Adherence, Obstructive Pulmonary Disease
To cite this article
Soheir M. Weheida, Manal E. Fareed, Samah E. Masry, Effect of Implementing an Educational Module About Inhaler Use on Severity of Dyspnea and Adherence to Inhalation Therapy Among Patients with Chronic Obstructive Pulmonary Disease, American Journal of Nursing Science. Vol. 6, No. 1, 2017, pp. 40-52. doi: 10.11648/j.ajns.20170601.16
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
World Health Organization. (2012). Retrieved from http://www.who.int/gho/publications /world_health_statstics/2012. Accessed on 27- 9- 2015
[2]
Rennard S. (2014) Patient information: Chronic obstructive pulmonary disease treatments. Lancet; (1): 1-6.
[3]
National Institute of Health: (2008). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary diseases. Retrieved on December 2015.
[4]
Chronic obstructive pulmonary disease (COPD) Fact sheet No 315. 2007: http://www.who.int/mediacentre/factsheets/fs315/en/index.html.
[5]
World Health Organization. (2016). Chronic respiratory diseases. Available at http://www.who.int/respiratory/copd/burden/en/ retrieved on 31/1/2016
[6]
Nunes D., Mota R., Neto O., Pereira E., de Bruin V. and de Bruin P. (2009). Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung; 187: 159-63.
[7]
National institute of health (2001) Global initiative for chronic obstructive pulmonary disease: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. U.S department of health and human services, NIH publication number 2701B.
[8]
Nunes D., Mota R., Neto O., Pereira E., de Bruin V. and de Bruin p.(2009) impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung; 187: 159-63.
[9]
Janssen D., Franssen F., Wouters E., Schols J. and Spruit M. (2011) Impaired health status and care dependency in patients with advanced COPD or chronic heart failure. Quality of life research; 20: 16, 79-88.
[10]
Rocker G., Horton R., Currow D., Goodridge D., Young J. and Booth S. (2009) Palliation of dyspnea in advanced COPD: Revisiting a role for opioids. Thorax; 64: 910–5.
[11]
Marciniuk D., Goodridge D., Hernandez P., Rocker G., Balter M., Bailey P., Ford G., Bourbeau J., O’Donnell D., Maltais F., Mularski R., Cave A., Mayers I., Kennedy V., Oliver T., and Brown C., (2011). Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline, Can Respir J; 18 (2): 69–78.
[12]
Global Initiative for Chronic Obstruction Lung Disease (2011). Global strategy of the diagnosis, management and prevention of chronic obstructive pulmonary disease. The GOLD Workshop Report, 65-86. Available at http:// www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html retrieved on 27- 9- 2015
[13]
Crompton G., Barnes P. Broeders M., Corrigan C., Corbetta L. and Dekhuijzen, R. (2006). The need to improve inhalation technique in Europe: A report from the Aerosol drug management improvement team. Resp Med.; 100: 1479–94
[14]
Cochrane M., Bala M., Downs K., Josephine M and Ben-Joseph R. (2000). Inhaled corticosteroids for asthma therapy: Patient compliance, devices, and inhalation technique. Chest; 117, 542-50.
[15]
Roche N., Chrystyn H. Lavorini F. Agusti A. Virchow C. Dekhuijzen R. and Price D. (2013). Effectiveness of inhaler devices in adult asthma and COPD. EMJ Respir; 1 (1): 64–71.
[16]
Hesselink A., Penninx B and Wijnhoven H..(2001). Determinants of an incorrect inhalation technique in patients with asthma or COPD. Scan J Prim Health Care; 19: 255–60
[17]
National Asthma Council Australia. (2008). Inhaler technique in adults with asthma or COPD. Available at www. National asthma. org.au. 1-9 retrieved on 19-4-2016
[18]
Takemura M., Mitsui K., Ido M., Matsumoto M., Koyama M., Inoue D., Takamatsu K., Itotani R., Ishitoko M., Suzuki S., Aihara K., Sakuramoto M. Kagioka H. and Fukui M.(2013) Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients. International Journal of COPD; 8 (1): 239- 44.
[19]
Vestbo J., Anderson J. and Calverley P. (2009) Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax; 64 (11): 939- 43.
[20]
Kaplan R, Ries A. (2005). Quality of life as an outcome measure in pulmonary diseases. J Cardiopulm Rehabil. 25: 321–31.
[21]
Rodriguez-Roisin R. (2005). The airway pathophysiology of COPD: implications for treatment. Int J Chron Obstruct Pulmon Dis. 2005; 2: 253–62.
[22]
White R. Walker P., Roberts S., Kalisky S. and White P.(2006) Bristol COPD Knowledge Questionnaire: Testing what we teach patients about COPD. Chronic Respiratory Disease, 3, 123-31. dio: 10.1191/1469972306cd117oa.
[23]
Lee H., Boo S., Lim Y., Kim S. and Kim I. (2014) Accuracy of inhaler use in patients with COPD. Clinical Nursing Research; 23 (5): 560-74.
[24]
Eakin E., Resinkoff P., Prewitt L., Ries A. and Kaplan R.(1998) Shortness of breath questionnaire. Chest; 13 (1): 619-24.
[25]
Tabberer M., Brooks J. and Wilcox T.(2015) A meta analysis of four randomized clinical trials to confirm the reliability and responsiveness of the shortness of breath with daily activity questionnaire in chronic obstructive pulmonary disease. Health and quality of life outcomes; 13: 177
[26]
Morisky D., Green L. and Levine D. (1986) Concurrent and predictive validity of a self reported measure of medication adherence. Med Care; 24: 67-74.
[27]
Moharamazad Y., Saadat H., Shahraki N., Rai A., Saadat Z., Aerab- sheibani H., Naghizadeh M. and Morisky D. (2015) Validation of the Persian version of the 8 item Morisky medication adherence scale in Iranian hypertensive patients. Global Journal of health science; 7 (4): 7
[28]
Dawson B., and Trapp R., (2001): Reading the medical literature: Basic & Clinical Biostatistics. 3rd ed., New York. Lange Medical Book/ McGraw – Hill. Medical Publication Division, 7-9, 161-218, 305-14.
[29]
Lavorini F., Magnan A., Dubus J., Voshaar T., Corebetta L., Broedres M., Dekhuizen R., Sanchis J., Viejo J., Barnes P., Corrigan C., Levy M. and Crompton G.(2008). Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med.; 102 (1): 593-604.
[30]
Salah M., Hamdi A. and Shehata H.(2013). Improving breathlessness and fatigue in patients with COPD. Journal of American Science; 9 (12): 470-82.
[31]
Tel H., Bilgic Z. and Zorlu Z. (2012). Evaluation of dyspnea and fatigue among the COPD patients, Chronic obstructive pulmonary disease- current concepts and practice. Available at: http://www.intechopen.com/books/chronic obstructivepulmonary-disease-current-concepts and practice/evaluation of -dyspnea-and- fatigue-among the –copd patients.
[32]
Wiśniewski D., Porzezińska M., Gruchała-Niedoszytko M., Niedoszytko M., Marek J., Jassem W. (2014). Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations. Pneumonol. Alergol.; 82: 96-104.
[33]
Akinci A. and Yildirim E. (2013). Factors affecting health status in patients with chronic obstructive pulmonary disease. International journal of Nursing Practice; 19 (1): 31-8.
[34]
National Heart, Lung, and Blood Institute (2013). COPD are you at risk? Last updated 2011; accessed 2013 Feb 11.
[35]
Fernandez J., Fernandez F., Ruiz A., Torres D. and Fonseca P. (2014). Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease: A randomized controlled trial. BMC Pulmonary Medicine; 14: 70-83
[36]
Fadaei S., Pourahmad M., Asghari M., Kohan M. and Sepidkar a. (2014). Correct or incorrect use of inhalers in patients with dyspnea. Pars Journal of Medical science; 12 (2): 23-8.
[37]
Restrepo R., Alvarez M., Wittnebel L., Sorenson H., Wettstein R., Vines D., Sikkema- Ortiz J., Gardner D. and Wilkins R. (2008). Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis.; 3 (3): 371-84.
[38]
Bieber J. and Terkeltaub R. (2007). Gout: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum; 50 (3): 2400-14.
[39]
Khdour M., Kidncy J., Smyth B. and McElnay J. (2009). Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol.; 68 (4): 588-98.
[40]
Jarab A., Alqudah S., Khdour M., Shamssain M. and Mukattash T. (2012). Impact pharmaceutical care on health outcomes in patients with COPD. Int Clin Pharm.; 34 (1): 53- 62.
[41]
Elsayed H., Weheida S. Mohsen M. and Shehata A. (2012): The effect of knee range of motion exercise on knee pain and activity of daily living after arthroscopic anterior cruciate ligament reconstruction. Innovation in Nursing researches, education and practice. International conference of Kennesaw state and Helwan universities.
[42]
Rootmensen G., Van Keimpema A., Jansen H. and de Haan R. (2010). Predictors of incorrect inhalation technique in patients with asthma or COPD: A study using a validated videotaped scoring method. Journal of Aerosol Medicine and pulmonary drug delivery; 23: 1-6.
[43]
Marciniuk D., Goodridge D., Hernandez P., Rocker G., Balter M., Bailey P., Ford G., Bourbeau J. O'Donnell D., Maltais F., Mularski R., Cave A., Mayers I., Kennedy V., Oliver T. and Brown C. (2011). Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian thoracic society clinical practice guideline. Can Respir J.; 18 (2): 69- 78.
[44]
Rabe K. (2006). Improving dyspnea in chronic obstructive pulmonary disease optimal treatment stratigies. ATS Journals.; 3 (3) 270-5.
[45]
Melani A., Bonavia M., Cilenti V., Cinti C., Lodi M., Martucci P. and Neri M. (2011). Inhaler mishandling remains common in real life and is associated with reduced disease control. Respiratory Medicine; 105 (1): 930-38.
[46]
Lee H., Boo S., Lim Y., Kim S. and Kim I. (2014). Accuracy of inhaler use in patients with chronic obstructive pulmonary disease. Clinical Nursing Research; 23 (5): 560- 74.
[47]
Stuart B. (2004). Navigating the new medicare drug benefit. Am J Geriatr Pharmacother. Pub Med.; 2: 75-80.
[48]
Krigsman K., Lars J. and Ring L. (2007). Refill adherence for patients with asthma and COPD: Comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacopidemiol Drug Saf.; 16 (1): 441-8.
[49]
Haupt D., Krigsman K. and Nilsson J. (2008). Medication persistence among patients with asthma/COPD drugs. Pharm World Sci.; 5.
[50]
Agh T., Inotai A., Meszaros A. (2011). Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration; 82: 328-34.
[51]
Di Matteo M., Haskard K. and Williams S. (2007). Health beliefs, disease severity and patient adherence: A meta analysis. Med care; 45 (1): 521-8.
[52]
Ammari W. and Chrystyn H. (2013). Optimizing the inhalation flow and technique through metered dose inhalers of asthmatic adults and children attending a community pharmacy. J Asthma; 50: 505-13.
[53]
Takemura M., Mitsui K., Ido M., Matsumoto M., Koyama M., Inoue D., Takamatsu K., Itotani R., Ishitoko M., Suzuki s., Aihara K., Sakuramoto M., Kagioka H. and Fukui M. (2013). Effect of a network system for providing proper inhalation technique by community pharmacist on clinical outcomes in COPD patients. Int J Chron Obstruct Pulmon Dis.; 8: 239-44.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186